biotech · Glaucoma · Hepatocellular Carcinoma · AEON
AEON Biopharma
AEON Biopharma clinical programs — 9 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- irvine, USA
- Employees
- 11
- Programs
- 9
- Drugs
- 8
- Patents
- 9
AEON Biopharma projects
9 ClinicalTrials.gov programs sponsored by AEON Biopharma.
AEON Biopharma has 9 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
ABP-450
AEON Biopharma
Cervical Dystonia
2 trials -
ABP-450
AEON Biopharma
Migraine
2 trials -
Mitomycin C
AEON Biopharma
Glaucoma
1 trial -
Provisc
AEON Biopharma
Steroid Induced Glaucoma
1 trial -
ET1402L1-ARTEMIS™ T cells -IV
AEON Biopharma
Hepatocellular Carcinoma
1 trial -
Ologen Collagen Matrix
AEON Biopharma
Congenital Glaucoma
1 trial -
autologous ET1402L1-CART cells
AEON Biopharma
Hepatocellular Carcinoma
1 trial -
Use of Mitomycin-C (MMC) in trabeculectomy
AEON Biopharma
Glaucoma
1 trial -
Use of Mitomycin-C in trabeculectomy
AEON Biopharma
Open-angle Glaucoma
1 trial
Frequently asked questions
How many clinical projects does AEON Biopharma have?
9 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.